BackgroundPreoperative knowledge of mutational status of gastrointestinal stromal tumors (GISTs) is essential to guide the individualized precision therapy. This study aims to establish a...
BackgroundKIT and / or PDGFRA activation mutation is the initial molecular event of gastrointestinal stromal tumor (GIST), and the molecular mechanism leading to the malignant progression...
BackgroundPancreatic cancer is a disease with high mortality. In most cases, it is diagnosed in advanced stages and median overall survival is less than 12 months. Time to diagnosis and t...
BackgroundWhile treatment with single agent ICI does not lead to positive tumor responses in the majority of Microsatellite Stable (MSS) advanced G/E adenocarcinoma, a minority group show...
BackgroundColorectal cancer (CRC) is among the most malignancies with limited treatments other than surgery and increased steadily. The prognosis of CRC patients is greatly influenced by ...
BackgroundPancreatic cancer is associated with the highest risk of thromboembolism, with incidence rates between 5% to 41%, the highest compared to any other cancer type. COVID-19 is an e...
BackgroundColon adenocarcinoma (CC) is the fourth cause of death worldwide. The prognosis of newly diagnosed CC is mainly based on the clinical stage; however, CC is considered a complex ...
BackgroundPancreatic cancer is rated as the 12th most frequent cancer in the world and 6th in Albania. Men have a higher incidence than women, with a global incidence of 5.5 per 100,000 f...
BackgroundSeveral studies report that nutritional status and other proinflammatory markers, such as neutrophil-to-lymphocyte ratio (NLR), affect the prognosis of various malignant tumors....
BackgroundTransgenders are individuals with a gender identity that differs from their sex at the time of birth. Over > 1.6 million adults identify themselves as transgender in the US, ...